Overview
- 53 inspections across 50 sites are on record.
- 277 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-09-29.
At a glance
Inspections
53
Sites
50
Observations
277
Career since
Feb 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Genus Lifesciences Inc. | 29 Sep 2017 | Human Drugs | View 483 → |
| Sindan-Pharma SRL | 28 Jul 2017 | Human Drugs | View 483 → |
| KYMOS S.L. | 18 Jul 2017 | Human Drugs | View 483 → |
| Copersam Red SL | 13 Jul 2017 | Human Drugs | On file |
| North American Ingredients | 24 May 2017 | Human Drugs |
Sites inspected
Genus Lifesciences Inc.Allentown, United States1 insp.
Sindan-Pharma SRLBucharest, Romania1 insp.
KYMOS S.L.Cerdanyola Del Valles, Spain1 insp.
Copersam Red SLZuera, Spain1 insp.
North American IngredientsScarborough, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Eric L Dong4 shared
Doan T Nguyen3 shared
James M Simpson3 shared
Ashley L Reiber3 shared
Justin A Boyd2 shared
Qin Xu2 shared
Jonathan W Chapman2 shared
Zhongren Wu2 shared
Nebil A Oumer2 shared
Stacie A Woods1 shared
Full investigator report
Get the verbatim findings behind Toyin B Oladimeji's 277 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site